Pioneering Advancements

Fertility research and innovation has come a long way since the birth of Elizabeth Carr, the first US IVF birth in December 1981. And the experts from Reproductive Medicine Associates of New Jersey have provided significant and seminal contributions for nearly 20 years support hopeful patients become parents. The result of our efforts in research and innovation have produced IVF success rates well over the US average for more than 10 years.

RMANJ’s commitment to advancement and innovation is demonstrated in more than 400 scientific papers and peer-reviewed articles published in just the last several years.  RMANJ has been nominated for the general program prize paper at the American Society for Reproductive Medicine Meeting (ASRM) five times in the last several years, and won the honor three times – in 2007 , 2010 and 2016. Members of the RMANJ team have won prize papers seven times – an unparalleled achievement. The team continues to strive for improved efficacy and safety in IVF treatment across a number of areas including:

  • Embryology
  • Molecular Genetics
  • Transcriptomics
  • Genomics

Recent Research

Below is a list of helpful resources published by RMANJ physicians. Simply click on the title of the article to view the PDF.

In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial
– Forman EJ; Hong KS; Ferry KM; Tao X; Taylor D; Levy B; Treff NR; Scott RT Jr.  In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial.  Fertility & Sterility. July 2013; 100(1):100-107.

Single embryo transfer with comprehensive chromosome screening results in improved ongoing pregnancy rates and decreased miscarriage rates.
– Forman EJ; Tao X; Ferry KM; Taylor D; Treff NR; Scott RT Jr.  Single embryo transfer with comprehensive chromosome screening results in improved ongoing pregnancy rates and decreased miscarriage ratesHuman Reproduction. April 2012; 27(4):1217-22.

Tracking embryo implantation using cell-free fetal DNA enriched from maternal circulation at 9 weeks gestation.
– Treff  NR, Tao X,  Su J, Lonzcak A., Northrop L.,  A. Ruiz, Scott RT.   Tracking embryo implantation using cell-free fetal DNA enriched from maternal circulation at 9 weeks gestationMol. Hum. Reprod. July 2011; 17(7):434-438.

Single-cell whole-genome amplification technique impacts the accuracy of SNP microarray-based genotyping and copy number analyses.
– Treff NR, Su J, Tao X, Northrop L., Scott RT.  Single Cell Whole Genome Amplification Technique Impacts the Accuracy of SNP Microarray Based Genotyping and Copy Number Analyses. Mol. Hum. Reprod. June 2011; 17(6 ): 335–343.

SNP microarray-based 24 chromosome aneuploidy screening is significantly more consistent than FISH.
– Treff  NR, Levy B., Su J. ,Northrop L., Tao X, Scott RT.  SNP microarray based 24 chromosome aneuploidy screening is significantly more consistent than FISH. Mol. Hum. Reprod. Aug 2010; 16(8):583-9.

SNP microarray-based 24 chromosome aneuploidy screening demonstrates that cleavage-stage FISH poorly predicts aneuploidy in embryos that develop to morphologically normal blastocysts.
– Northrop L., Treff  NR, Levy B., Scott RT.  SNP microarray based 24 chromosome aneuploidy screening demonstrates that   cleavage stage FISH poorly predicts aneuploidy in embryos that develop to morphologically normal blastocysts.  Mol. Hum. Reprod. Aug 2010; 16(8):590-600.